Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical
Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution
Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis